Cellosaurus MOR/0.2R (CVCL_2126)
| Cell line name | MOR/0.2R |
|---|---|
| Accession | CVCL_2126 |
| Resource Identification Initiative | To cite this cell line use: MOR/0.2R (RRID:CVCL_2126) |
| Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: In situ; Lung; UBERON=UBERON_0002048. |
| Disease | Lung adenocarcinoma (NCIt: C3512) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_2618 (MOR) |
| Sex of cell | Sex unspecified |
| Age at sampling | Age unspecified |
| Category | Cancer cell line |
| Publications | PubMed=7903701; DOI=10.1093/jnci/86.2.110 |
| Cross-references | |
| Cell line collections (Providers) | ECACC; 96042335 |
| Cell line databases/resources | CLO; CLO_0007833 |
| Encyclopedic resources | Wikidata; Q54906389 |
| Entry history | |
| Entry creation | 04-Apr-2012 |
| Last entry update | 19-Dec-2024 |
| Version number | 11 |